Pocket Emergency Medicine (Pocket Notebook Series) 3rd Ed.

JAUNDICE

Definition

• Yellowish discoloration of the skin/tissue/body fluids caused by ↑ bilirubin production or ↓ excretion

Approach

• Bilirubin: Formed from degradation of hemoglobin → bound to albumin in blood (unconjugated/indirect) → conjugated in liver by glucuronyltransferase (conjugated/direct) → excreted in bile

History

• Differential depends on age (neonates ≤4 wk), gestational age, breast-feeding status

• Time of onset of sx: Yellowing of skin, dark urine

Physical Findings

• Scleral icterus, jaundice

Labs

• Total/fractionated bilirubin (visible >5 mg/dL in neonates), LFTs, CBC (hemolysis/anemia → Coombs test, smear, ABO/Rh type), reticulocyte count, serum haptoglobin

• Neonates → unconjugated (can be physiologic, treat to prevent kernicterus)/conjugated (always pathologic)

PHYSIOLOGIC JAUNDICE

Definition

• Elevated unconjugated bilirubin in the 1st wk of life, 60% newborns will be jaundiced (peaks 2–5 d), due to low activity of glucuronyltransferase

Evaluation

• Total/fractionated bilirubin, CBC (hemolysis/anemia → Coombs test, smear, ABO/Rh type), total bilirubin usually <6 mg/dL, up to 12 mg/dL in premature infants

Treatment

• No tx necessary

Disposition

• Home

Pearls

• Pathologic: In the 1st 24 h of life, peak >17 mg/dL in breast-fed/>15 mg/dL in formula-fed infants, persists beyond 1st wk of life, ↑ bilirubin >5 mg/dL/d

• Cx of severe hyperbilirubinemia: kernicterus (bilirubin deposition in basal ganglia → neurodevelopmental deficits)

• Sepsis can rarely present as jaundice

BREAST-FEEDING JAUNDICE

Definition

• ↑ unconjugated bilirubinemia in breast-fed infants possibly due to hormonal mediators or altered intestinal secretion/absorption of bile, early onset after birth

Evaluation

• Total/fractionated bilirubin, CBC

Treatment

• No tx necessary if bilirubin <17 mg/dL, continue breast feeding, phototherapy

Disposition

• Home

BREAST MILK JAUNDICE

Definition

• Due to substances in breast milk that prevent conjugation & excretion of bilirubin. Occurs after 3–5 d of life, persists for weeks.

Evaluation

• Total/fractionated bilirubin, CBC

Treatment

• If bilirubin <17 mg/dL, continue breast feeding, phototherapy

• If >17 mg/dL, stop breast feeding, will not recur when resumed

Disposition

• Home

ABO AND RH INCOMPATIBILITY/HEMOLYTIC DISEASE

Definition

• Hemolytic dz caused by maternal antibodies against fetal A or B type proteins or maternal Rh antibodies (sensitized from previous pregnancy) against Rh-positive fetus (Rh incompatibility)

History

• Yellowing of skin w/i 1st 24 h of life, dark urine, lethargy

Physical Findings

• Severe jaundice, scleral icterus, ill appearing

Evaluation

• Total/fractionated bilirubin, CBC (hemolysis/anemia → Coombs test, smear, ABO/Rh type)

Treatment

• Phototherapy, exchange transfusion (see table)

Disposition

• Admit

CONJUGATED HYPERBILIRUBINEMIA

Definition

• Pathologic increase in direct bilirubin leading to jaundice (conjugated bilirubin >20% of total, or >2 mg/dL)

History

• Yellowing of skin, dark urine, lethargy, ±genetic syndrome/metabolic syndromes/sepsis

Physical Findings

• Severe jaundice, scleral icterus, ill appearing

Evaluation

• Total/fractionated bilirubin, CBC, blood cultures, blood smear, LFTs, blood type, KUB if signs of obstruction, U/S: Biliary obstruction, UA, Ucx

Treatment

• Hydration, tx based on cause (see below)

Disposition

• Admit



If you find an error or have any questions, please email us at admin@doctorlib.org. Thank you!